Jason Kipnis and Danny Salazar criticized Indians’ play after suffering a four-game sweep against the White Sox

6 Comments

The Indians dropped all four games in a Thursday-through-Sunday set against the White Sox, including a heartbreaking 2-1 loss on Sunday afternoon. Starter Danny Salazar pitched well, allowing only two runs in 6 2/3 innings, but his offense couldn’t muster anything against opposing starter Carlos Rodon.

As a result, the Indians sit in last place in the AL Central at 45-52. They’ve lost eight of their last 11 games, and neither Salazar nor Kipnis are all that impressed with the team’s energy.

Via MLB.com’s August Fagerstrom and Chris Assenheimer of the Chronicle-Telegram:

Kipnis and Salazar have both done their best to help the club, as Kipnis entered the day with an .882 OPS and Salazar lowered his ERA to 3.72 following his start.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.